Oligonucleotide CRDMO Platform

WuXi TIDES has a robust and integrated Oligo API Platform, offering R&D and manufacturing services from preclinical to commercial scale and operating out of our US FDA inspected facility based in Changzhou, China. We support the development and manufacture of a variety of oligonucleotide modalities including DNA, RNA, Phosphorodiamidate Morpholino Oligomers (PMO) and peptide conjugates (ex. PPMO), and more. Oligonucleotide capabilities include: - Full Suite Discovery Platform to go from monomer→ oligo → conjugate' - Process R&D - Manufacturing capability ranging from grams to multi kilograms - Analytical characterization - Method development and validation - IPC & release testing - ICH compliant stability studies - Regulatory (CMC) submission support.